|
Substance P (2-11)/Deca-Substance P
|
|
53749-61-4
|
|
[D-Pro4,D-Trp7,9,10]-Substance P (4-11)
|
|
86917-57-9
|
|
Ac-VEID-pNA
|
|
189684-54-6
|
|
pp60 c-src (521-533)
|
|
198754-34-6
|
|
Hepcidin-22 (human) trifluoroacetate salt
|
|
342790-22-1
|
|
Urotensin II , human
|
|
251293-28-4
|
|
Urocortin (rat) (free acid)
|
|
171543-83-2
|
|
Ac-YVAD-pNA
|
|
149231-66-3
|
|
Z-Ala-Ala-Leu-pNA
|
|
61043-33-2
|
|
Calcineurin Substrate
|
|
113873-67-9
|
|
[D-Ala4]-Substance P (4-11)
|
|
81381-50-2
|
|
p60c-src Substrate I
|
|
165190-42-1
|
|
PKCe pseudosubstrate derived peptide
|
|
120253-69-2
|
|
MMP-7 Substrate I, fluorogenic
|
|
172666-82-9
|
|
[Pyr5]-Substance P (5-11)
|
|
56104-22-4
|
|
[D-Pro2, D-Trp7,9]-Substance P
|
|
80434-86-2
|
|
[D-Arg1,D-Trp5,7,9,Leu11]-Substance P
|
|
122481-75-8
|
|
[D-Pro4,D-Trp7,9,Nle11]-Substance P (4-11)
|
|
89430-34-2
|
|
[D-Trp2,7,9]-Substance P
|
|
100930-11-8
|
|
Biotin-(Arg8)-Vasopressin
|
|
126703-17-1
|
|
[Arg8]-Vasopressin (free acid)
|
|
25255-33-8
|
|
Vasoactive Intestinal Contractor [VIC]
|
|
120928-04-3
|
|
VIP, guinea pig
|
|
96886-24-7
|
|
[Ala11,22,28]-VIP (human, bovine, porcine, rat)
|
|
291524-04-4
|
|
Urocortin III, human
|
|
357952-09-1
|
|
Ac-Phe-Gly-pNA
|
|
34336-99-7
|
|
Cathepsin S substrate
|
|
1135686-31-5
|
|
Protein Kinase p34(cd2) Substrate; CSH 103
|
|
135546-44-0
|
|
[Pyr6]-Substance P (6-11)
|
|
61123-13-5
|
|
Substance P (9-11)
|
|
4652-64-6
|
|
TRH-Gly
|
|
85344-77-0
|
|
TRH
|
|
24305-27-9
|
|
[Glu2]-TRH
|
|
85541-78-2
|
|
[Arg8]-Vasopressin
|
|
113-79-1
|
|
pp60(v-SRC) Autophosphorylation Site, Protein Tyrosine Kinase Substrate
|
|
81493-98-3
|
|
Protein Kinase A Substrate
|
|
57836-10-9
|
|
[Tyr0]-Urocortin (rat)
|
|
187111-93-9
|
|
[Trp11] Neurotensin (8-13)
|
|
39379-15-2
|
|
Neurotensin (8-13), N-Acetyl
|
|
74853-69-3
|
|
Orn8, Urotensin II, human
|
|
479065-85-5
|
|
228544-21-6
|
|
228544-21-6
|
|
Hepcidin-20 (human) trifluoroacetate salt
|
|
342790-23-2
|
|
Hepcidin-1 (mouse) trifluoroacetate salt
|
|
1676104-75-8
|
|
Tyrosinase (243-251) (human)
|
|
197171-78-1
|
|
Tyrosinase (192-200) (human, mouse)
|
|
170294-35-6
|
|
Prepro TRH (178-199)
|
|
122018-92-2
|
|
Boc-GRR-AMC
|
|
113866-14-1
|
|
Ac-IETD-pNA
|
|
219138-21-3
|
|
Ac-IEAR-pNA
|
|
189950-66-1
|
|
Caspase 3 Substrate 1m (Apopain), fluorogenic; Ac-DEVD-AMC
|
|
169332-61-0
|
|
Caspase 1 Substrate 2m (ICE), fluorogenic; Ac-YVAD-AMC
|
|
149231-65-2
|
|
Akt Specific Substrate Peptide, Akt/PKB
|
|
276680-69-4
|
|
[Arg8]-Vasopressin (4-9)
|
|
96027-30-4
|
|
FluM1 A2 (58-66)
|
|
141368-69-6
|
|
Val-Asp-(Arg8)-Vasopressin
|
|
100930-18-5
|
|
Xenopsin-Related Peptide 1 (XP-1)
|
|
117442-28-1
|
|
Xenopsin (XP)
|
|
51827-01-1
|
|
[Arg8,des-Gly-NH29]-Vasopressin
|
|
37552-33-3
|
|
VIP, Antagonist
|
|
125093-93-8
|
|
[Arg8]-Vasotocin
|
|
113-80-4
|
|
Valorphin
|
|
144313-54-2
|
|
[Pyr16]-VIP (16-28) (human, bovine, porcine, rat)
|
|
134907-86-1
|
|
VIP (10-28) (human, bovine, porcine, rat)
|
|
69856-17-3
|
|
VIP (6-28) (human, bovine, porcine, rat)
|
|
69698-54-0
|
|
Neurotensin (1-8)
|
|
80887-44-1
|
|
Prepro VIP (156-170) (human)
|
|
107902-86-3
|
|
VIP (1 - 12), human, porcine, rat
|
|
120928-03-2
|
|
AKT/PKB/Rac - Protein Kinase Substrate
|
|
324029-01-8
|
|
[Ser25] - PKC (19 - 36) Substrate
|
|
113715-84-7
|
|
Myelopeptide-2 (MP-2)
|
|
135861-77-7
|
|
Adrenorphin
|
|
88377-68-8
|
|
[Lys8,Lys9]-Neurotensin (8-13)
|
|
139026-64-5
|
|
Neurotensin (1-11)
|
|
74032-89-6
|
|
Neurotensin (8-13)
|
|
60482-95-3
|
|
Urocortin II, human
|
|
398001-88-2
|
|
TRH, Free Acid
|
|
34367-54-9
|
|
Phosphatase Substrate
|
|
333338-18-4
|
|
[Tyr6,D-Phe7,D-His9]-Substance P (6-11)
|
|
145194-26-9
|
|
Protein Kinase C Substrate
|
|
105802-82-2
|
|
TNF-α (31-45), human
|
|
144796-71-4
|
|
cAMP Dependent Protein Kinase Substrate
|
|
65189-70-0
|
|
[D-Pro2,D-Phe7,D-Trp9]-Substance P
|
|
77275-70-8
|
|
TNF-α (46-65) (human)
|
|
144796-72-5
|
|
TNF-α (10-36) (human)
|
|
144796-70-3
|
|
Substance P (5-11)/Hepta-Substance P
|
|
51165-09-4
|
|
Substance P (4-11)/Octa-Substance P
|
|
53749-60-3
|
|
[D-Glu5,D-Trp7,9,10]-Substance P (5-11)
|
|
289632-61-7
|
|
[D-Trp11]-Neurotensin
|
|
73634-68-1
|
|
Urotensin I
|
|
83930-33-0
|
|
MMP-8 Substrate, fluorogenic
|
|
135662-05-4
|
|
Substance P (6-11)/Hexa-Substance P
|
|
51165-07-2
|
|
Neurotensin (9-13)
|
|
60482-96-4
|
|
[Pyr6,Pro9]-Substance P (6-11)
|
|
79775-19-2
|
|
Urocortin III, mouse
|
|
357952-10-4
|
|
TRH-AMC
|
|
190836-86-3
|
|
[Asp371] Tyrosinase(369-377), human
|
|
168650-46-2
|
|
[D-Arg1,D-Pro2,D-Phe7,D-His9]-Substance P
|
|
115760-58-2
|
|
MMP Substrate I, fluorogenic
|
|
121282-17-5
|
|
Substance P-methyl ester
|
|
76260-78-1
|
|
Abl Cytosolic Substrate
|
|
168202-46-8
|